Runx2 deletion in smooth muscle cells inhibits vascular osteochondrogenesis and calcification but not atherosclerotic lesion formation.
OBJECTIVE
Vascular smooth muscle cells (SMCs) are major precursors contributing to osteochondrogenesis and calcification in atherosclerosis. Runt-related transcription factor-2 (Runx2) has been found essential for SMC differentiation to an osteochondrogenic phenotype and subsequent calcification in vitro. A recent study using a conditional targeting allele that produced a truncated Runx2 protein in SMCs of ApoE-/- mice showed reduced vascular calcification, likely occurring via reduction of receptor activator of nuclear factor-κB ligand (RANKL), macrophage infiltration, and atherosclerotic lesion formation. Using an improved conditional Runx2 knockout mouse model, we have elucidated new roles for SMC-specific Runx2 in arterial intimal calcification (AIC) without effects on atherosclerotic lesion size.


RESULTS
We used an improved targeting construct to generate LDLr-/- mice with floxed-Runx2 alleles ( LDLr-/- :Runx2 f/f ) such that Cre-mediated recombination ( LDLr-/- :Runx2 ΔSM ) does not produce functional truncated Runx2 protein, thereby avoiding off-target effects. We found that both LDLr-/- :Runx2 f/f and LDLr-/- :Runx2 ΔSM mice fed with a high fat diet developed atherosclerosis. SMC-specific Runx2 deletion did not significantly reduce atherosclerotic lesion size, macrophage number, or expression of RANKL, MCP-1, and CCR2. However, it significantly reduced AIC by 50%. Mechanistically, Sox9 and type II collagen were unaltered in vessels of LDLr-/- :Runx2 ΔSM mice compared to LDLr-/- :Runx2 f/f counterparts, while type X collagen, MMP13 and the osteoblastic marker osteocalcin were significantly reduced.


CONCLUSIONS
SMC autonomous Runx2 is required for SMC differentiation towards osteoblast-like cells, SMC-derived chondrocyte maturation and AIC in atherosclerotic mice. These effects were independent of systemic lipid metabolism, RANKL expression, macrophage infiltration, and atheromatous lesion progression.
Present address. RevMAb Biosciences, 870 Dubuque Ave, South San Francisco, CA 94080, USA.
Mu-En
ME
Lin
Theodore M
TM
Chen
Mary C
MC
Wallingford
Present address. University of Washington School of Medicine, Seattle, WA 98195, USA.
Ngoc B
NB
Nguyen
Shunsuke
S
Yamada
Present address. Department of Pharmacology, Faculty of Veterinary Science, Chulalongkorn University, Bangkok 10330, Thailand.
Chenphop
C
Sawangmake
Jaimei
J
Zhang
Mei Y
MY
Speer
Cecilia M
CM
Giachelli
J Am Coll Cardiol. 1992 May;19(6):1167-72
1564217
Cell. 1997 May 30;89(5):755-64
9182763
Kidney Int. 2003 Mar;63(3):1003-11
12631081
Dev Cell. 2012 Mar 13;22(3):597-609
22421045
Cardiovasc Res. 2012 Jun 1;94(3):545-54
22436847
Curr Opin Genet Dev. 2009 Oct;19(5):437-43
19836226
Genes Dev. 2006 Nov 1;20(21):2937-42
17050674
J Bone Miner Res. 2015 Jan;30(1):71-82
25079226
Circulation. 1995 Oct 15;92 (8):2157-62
7554196
Stroke. 2002 Feb;33(2):462-5
11823653
Am J Pathol. 2011 Feb;178(2):764-73
21281809
Circulation. 2014 Apr 15;129(15):1551-9
24481950
J Biol Chem. 2008 May 30;283(22):15319-27
18378684
Am J Roentgenol Radium Ther Nucl Med. 1964 Oct;92:865-71
14215099
Circulation. 2007 Jan 23;115(3):377-86
17224478
Curr Opin Lipidol. 2014 Oct;25(5):327-32
25188916
J Cell Sci. 2004 Jan 26;117(Pt 3):417-25
14702386
Arterioscler Thromb Vasc Biol. 2003 Mar 1;23(3):489-94
12615658
J Am Coll Cardiol. 1998 Jan;31(1):126-33
9426030
Circ Res. 2012 Aug 17;111(5):543-52
22773442
Nat Med. 2015 Jun;21(6):628-37
25985364
Circ Res. 2009 Mar 27;104(6):733-41
19197075
Circulation. 2004 Nov 30;110(22):3424-9
15557374
Cell. 1997 May 30;89(5):765-71
9182764
Circ Res. 2001 Dec 7;89(12):1147-54
11739279
Genes Dev. 2002 Nov 1;16(21):2813-28
12414734
Arch Biochem Biophys. 2008 May 15;473(2):139-46
18395508
Nat Rev Immunol. 2007 Feb;7(2):105-17
17259967
Hum Pathol. 2003 Apr;34(4):402-7
12733123
Cell. 1997 May 30;89(5):773-9
9182765
J Clin Invest. 2004 Sep;114(5):659-68
15343384
J Cell Biol. 2004 Jul 5;166(1):85-95
15226309
J Pathol. 2005 Apr;205(5):641-50
15776485
Stroke. 2002 May;33(5):1214-9
11988593
J Cell Physiol. 2007 Jun;211(3):728-35
17226753
Circulation. 2000 Mar 21;101(11):1243-8
10725282
Circulation. 1999 Nov 23;100(21):2168-76
10571976
Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7731-6
12796513
J Am Assoc Lab Anim Sci. 2007 May;46(3):47-52
17487953
PLoS One. 2012;7(3):e33313
22479382
Cardiovasc Pathol. 2013 Mar-Apr;22(2):167-75
22818582
Genes Dev. 1999 Apr 15;13(8):1025-36
10215629
Nat Rev Cardiol. 2010 Sep;7(9):528-36
20664518
Arterioscler Thromb Vasc Biol. 2015 Mar;35(3):535-46
25573853
Circulation. 2011 Mar 22;123(11):1216-26
21382888
Exp Cell Res. 2009 Aug 1;315(13):2231-40
19306868
Am J Pathol. 2015 Jul;185(7):1958-69
25987250
J Bone Miner Res. 2014 Dec;29(12):2653-65
24862038
Circ Res. 2013 Jun 21;113(1):72-7
23616621
FASEB J. 2003 Sep;17(12):1751-3
12958198
J Cell Biochem. 2010 Jul 1;110(4):935-47
20564193